trial · primary record
LY3954068
Alzheimer Disease
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 56 |
| Primary completion | 2028-07 |
| Primary endpoint | Part A: Number of participants with one or more Adverse Event (s) (AEs), Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Event(s) (SAEs) considered by the investigator to be related to study drug administration |
| Registry ID | NCT06297590 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:35:13.665Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06297590
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.